Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Tatjana Crnogorac-Jurcevic"'
Autor:
Nurshad Ali, Silvana Debernardi, Evelyn Kurotova, Jian Tajbakhsh, Nirdesh K. Gupta, Stephen J. Pandol, Patrick Wilson, Stephen P. Pereira, Bill Greenhalf, Oleg Blyuss, Tatjana Crnogorac-Jurcevic
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related death worldwide. Up to now, no specific screening or diagnostic tests are available for early PDAC detection. As a result, most patients are diagnosed with advance
Externí odkaz:
https://doaj.org/article/10656395436a4094a4771fd148554943
Autor:
Silvana Debernardi, Lukasz Liszka, Chara Ntala, Katja Steiger, Irene Esposito, Emanuela Carlotti, Ann‐Marie Baker, Stuart McDonald, Trevor Graham, Branko Dmitrovic, Roger M. Feakins, Tatjana Crnogorac‐Jurcevic
Publikováno v:
Molecular Oncology, Vol 18, Iss 3, Pp 677-690 (2024)
The median age of patients with pancreatic ductal adenocarcinoma (PDAC) at diagnosis is 71 years; however, around 10% present with early‐onset pancreatic cancer (EOPC), i.e., before age 50. The molecular mechanisms underlying such an early onset ar
Externí odkaz:
https://doaj.org/article/28e44b0fd78246999dcb6ae2e2fb819c
Autor:
Tatjana Crnogorac-Jurcevic
Publikováno v:
Advances in Biomarker Sciences and Technology, Vol 6, Iss , Pp 83-90 (2024)
The art of uroscopy (Greek ouron-urine and skopeo-examination), the visual inspection of urine, is as old as the history of mankind. It had seen its ups and downs, was praised and derided, but was ultimately perfected to become a complex visual and t
Externí odkaz:
https://doaj.org/article/b164d73d6b594736b353d8840a799adf
Autor:
Kathrin Schilling, Heng Chen, Ronald A. Glabonjat, Silvana Debernardi, Oleg Blyuss, Ana Navas-Acien, Alex N. Halliday, Tatjana Crnogorac-Jurcevic
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundMore than 700 million people worldwide suffer from diseases of the pancreas, such as diabetes, pancreatitis and pancreatic cancer. Often dysregulation of potassium (K+) channels, co-transporters and pumps can promote development and progres
Externí odkaz:
https://doaj.org/article/00b9566a51f64af6a7e328b49122e5f9
Publikováno v:
Advances in Biomarker Sciences and Technology, Vol 6, Iss , Pp 226- (2024)
Externí odkaz:
https://doaj.org/article/f62bc02b14d54e37afa9d88b505ddf0c
Autor:
Michelle R. Goulart, Jennifer Watt, Imran Siddiqui, Rita T. Lawlor, Ahmet Imrali, Christine Hughes, Amina Saad, Joanne ChinAleong, Chris Hurt, Catrin Cox, Roberto Salvia, Alberto Mantovani, Tatjana Crnogorac-Jurcevic, Somnath Mukherjee, Aldo Scarpa, Paola Allavena, Hemant M. Kocher
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-10 (2021)
Abstract Pancreatic ductal adenocarcinoma (PDAC), characterized by dense desmoplastic stroma laid down by pancreatic stellate cells (PSC), has no reliable diagnostic biomarkers for timely detection. A multi-center cohort of PDAC patients and controls
Externí odkaz:
https://doaj.org/article/e6dda48966e7423ba07476657d983905
Publikováno v:
Biology, Vol 12, Iss 2, p 158 (2023)
The correlation between pancreatic ductal adenocarcinoma (PDAC) and diabetes-related mechanisms support the hypothesis that early therapeutic strategies targeting diabetes can contribute to PDAC risk reduction and treatment improvement. A systematic
Externí odkaz:
https://doaj.org/article/b9924bbf365a419fbf6bbe2ab3a11038
Autor:
Wasfi Alrawashdeh, Richard Jones, Laurent Dumartin, Tomasz P. Radon, Pedro R. Cutillas, Roger M. Feakins, Branko Dmitrovic, Ihsan Ekin Demir, Guralp O. Ceyhan, Tatjana Crnogorac‐Jurcevic
Publikováno v:
Molecular Oncology, Vol 13, Iss 5, Pp 1075-1091 (2019)
Perineural invasion (PNI) is a common and characteristic feature of pancreatic ductal adenocarcinoma (PDAC) that is associated with poor prognosis, tumor recurrence, and generation of pain. However, the molecular alterations in cancer cells and nerve
Externí odkaz:
https://doaj.org/article/249791bfa1a843bb877926ad1eda4076
Autor:
Silvana Debernardi, Harrison O'Brien, Asma S Algahmdi, Nuria Malats, Grant D Stewart, Marija Plješa-Ercegovac, Eithne Costello, William Greenhalf, Amina Saad, Rhiannon Roberts, Alexander Ney, Stephen P Pereira, Hemant M Kocher, Stephen Duffy, Oleg Blyuss, Tatjana Crnogorac-Jurcevic
Publikováno v:
PLoS Medicine, Vol 17, Iss 12, p e1003489 (2020)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with around 9% of patients surviving >5 years. Asymptomatic in its initial stages, PDAC is mostly diagnosed late, when already a locally advanced or metastatic disease
Externí odkaz:
https://doaj.org/article/758ce4bbd92c47ee997f083080f5b0de
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Early onset pancreatic cancer (EOPC), i.e. pancreatic ductal adenocarcinoma (PDAC) occurring in patients below 50 years of age, is rare and there is limited information regarding risk factors, molecular basis and outcome. This stu
Externí odkaz:
https://doaj.org/article/2ac162b1f07047b181dde2451a6d63d7